Report - Linfomi Indolenti Follicolari La terapia di La terapia: prima ...Parameter Phase III CVP Clinical Trial Phase II CHOP Phase III CHOP ORR 81% 100% 96% % CR 41% 87% 20%** TTP (median)

Please pass captcha verification before submit form